- Home
- NAC vs CLDX Comparison
NAC vs CLDX Comparison
Compare NAC & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAC
- CLDX
- Stock Information
- Founded
- NAC 1998
- CLDX N/A
- Country
- NAC France
- CLDX United States
- Employees
- NAC N/A
- CLDX N/A
- Industry
- NAC Investment Managers
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- NAC Finance
- CLDX Health Care
- Exchange
- NAC Nasdaq
- CLDX Nasdaq
- Market Cap
- NAC 1.6B
- CLDX 1.6B
- IPO Year
- NAC N/A
- CLDX 2008
- Fundamental
- Price
- NAC $11.41
- CLDX $24.46
- Analyst Decision
- NAC
- CLDX Strong Buy
- Analyst Count
- NAC 0
- CLDX 9
- Target Price
- NAC N/A
- CLDX $46.13
- AVG Volume (30 Days)
- NAC 307.3K
- CLDX 1.5M
- Earning Date
- NAC 01-01-0001
- CLDX 11-05-2025
- Dividend Yield
- NAC 4.33%
- CLDX N/A
- EPS Growth
- NAC N/A
- CLDX N/A
- EPS
- NAC N/A
- CLDX N/A
- Revenue
- NAC N/A
- CLDX $5,790,000.00
- Revenue This Year
- NAC N/A
- CLDX N/A
- Revenue Next Year
- NAC N/A
- CLDX N/A
- P/E Ratio
- NAC N/A
- CLDX N/A
- Revenue Growth
- NAC N/A
- CLDX N/A
- 52 Week Low
- NAC $9.32
- CLDX $14.40
- 52 Week High
- NAC $11.21
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- NAC 57.50
- CLDX 57.09
- Support Level
- NAC $11.13
- CLDX $24.02
- Resistance Level
- NAC $11.64
- CLDX $25.51
- Average True Range (ATR)
- NAC 0.08
- CLDX 1.16
- MACD
- NAC 0.01
- CLDX 0.14
- Stochastic Oscillator
- NAC 54.90
- CLDX 66.11
About NAC Nuveen California Quality Municipal Income Fund
Nuveen California Quality Municipal Income Fund is a diversified closed-end management investment company. Its objective is to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal and California state income taxes. It invests majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.